Jim Cramer - Mad MoneyInsmed INSMDON'T BUYJul 09, 2025

Too speculative. They lose money.

Jim Cramer - Mad Money

Unknown

Unlock Rating

$96.47

Stock price when the opinion was issued

$126.68

As of Sep 03, 2026. Market Open.

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

WATCH

Up 152% last year. They got FDA approval for one of their top drugs last year to treat a lung condition. It pulled back 18% last month due to a disappointing trial result in a drug. Worth watching this.

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase